Search Results - Mathangi Gopalakrishnan

Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder by Babajide Shenkoya, Mathangi Gopalakrishnan, Ahizechukwu C. Eke

Connect to this object online.

Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach by Babajide Shenkoya, Venkata Yellepeddi, Katrina Mark, Mathangi Gopalakrishnan

Connect to this object online.

An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate by Shamir N. Kalaria, Susan L. McElroy, Jogarao Gobburu, Mathangi Gopalakrishnan

Connect to this object online.

Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in "real‐world" administration by Ahmed M. Salem, Erik Dvergsten, Sanja Karovic, Michael L. Maitland, Mathangi Gopalakrishnan

Connect to this object online.

An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials by Rahul K. Goyal, Shamir N. Kalaria, Susan L. McElroy, Mathangi Gopalakrishnan

Connect to this object online.

Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data by Athanasios Chamzas, Eglis Tellez, Andrew SyBing, Jogarao V. S. Gobburu, Mathangi Gopalakrishnan

Connect to this object online.

A Practice‐Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE‐01) by Shamir N. Kalaria, Michael Armahizer, Paul McCarthy, Neeraj Badjatia, Jogarao V. Gobburu, Mathangi Gopalakrishnan

Connect to this object online.

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder by Celine M. Laffont, Eliford Ngaimisi, Mathangi Gopalakrishnan, Vijay Ivaturi, Malcolm Young, Mark K. Greenwald, Christian Heidbreder

Connect to this object online.